Literature DB >> 917111

Occurrence of a new class of tetrahydroisoquinoline alkaloids in L-dopa-treated parkinsonian patients.

C J Coscia, W Burke, G Jamroz, J M Lasala, J McFarlane, J Mitchell, M M O'Toole, M L Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 917111     DOI： 10.1038/269617a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  In vivo formation of histamine phosphopyridoxal cyclic compounds.

Authors:  D Kierska; K Sasiak; C Maśliński
Journal:  Agents Actions       Date:  1981-04

2.  Chronic L-DOPA treatment of mice: a behavioural and biochemical study.

Authors:  R Bailey; E Crisp; D M Jackson; O Jenkins
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

Review 3.  Dopamine, morphine, and nitric oxide: an evolutionary signaling triad.

Authors:  George B Stefano; Richard M Kream
Journal:  CNS Neurosci Ther       Date:  2009-11-13       Impact factor: 5.243

Review 4.  Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases.

Authors:  P Dostert; M Strolin Benedetti; G Dordain
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

5.  Subacute L-DOPA in mice: biochemical and behavioural effects.

Authors:  O Jenkins; R Bailey; E Crisp; D M Jackson
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

6.  Concise synthesis of α-cyano tetrahydroisoquinolines with a quaternary center via Strecker reaction.

Authors:  Yue Ji; Xue Zhang; Weiwei Han; Sichang Wang; Ya Wu; Keliang Zhang; Penghui Yang; Pei Xiao; Yitao Wei
Journal:  RSC Adv       Date:  2021-12-01       Impact factor: 3.361

Review 7.  Parkinson's disease, L-DOPA, and endogenous morphine: a revisit.

Authors:  George B Stefano; Kirk J Mantione; Milena Králíčková; Radek Ptacek; Hana Kuzelova; Tobias Esch; Richard M Kream
Journal:  Med Sci Monit       Date:  2012-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.